| RS1745947620 |
AP3B1
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS1746018557 |
VCAN
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1746070254 |
NIPBL
|
Health Risk |
Pathogenic |
— |
| RS1746249107 |
AP3B1
|
Health Risk |
Likely pathogenic |
AP3B1-related disorder, AP3B1-related disorder |
| RS1746297425 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1746312450 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS1746314040 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS1746359403 |
SLC30A5
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hydrops fetalis |
| RS1746377687 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS1746388061 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS1746389144 |
SLC6A19
|
Health Risk |
Pathogenic |
Neutral 1 amino acid transport defect, Neutral 1 amino acid transport defect |
| RS1746416323 |
XRCC4
|
Health Risk |
Likely pathogenic |
Short stature, microcephaly |
| RS1746468268 |
PIK3R1
|
Health Risk |
Conflicting classifications of pathogenicity |
Agammaglobulinemia 7, autosomal recessive |
| RS1746480237 |
AP3B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS1746506127 |
LIFR
|
Health Risk |
Likely pathogenic |
— |
| RS1746518336 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS1746589361 |
SLC30A5
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hydrops fetalis |
| RS17466213 |
LRRK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Parkinson disease 8, Autosomal dominant Parkinson disease 8 |
| RS1746670652 |
NADK2
|
Health Risk |
Pathogenic |
Progressive encephalopathy with leukodystrophy due to DECR deficiency, Progressive encephalopathy with leukodystrophy due to DECR deficiency |
| RS1746675692 |
TRIO
|
Health Risk |
Pathogenic |
— |
| RS1746681452 |
TRIO
|
Health Risk |
Likely pathogenic |
— |
| RS1746702381 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS1746703466 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS1746711848 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1746736672 |
LIFR
|
Health Risk |
Pathogenic |
Stüve-Wiedemann syndrome 1, Stüve-Wiedemann syndrome 1 |
| RS1746738845 |
MCCC2
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS1746741258 |
MCCC2
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS1746763024 |
TRIO
|
Health Risk |
Pathogenic |
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome, Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome |
| RS1746764895 |
TRIO
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1746777262 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS1746792277 |
PIK3R1
|
Health Risk |
Pathogenic |
Immunodeficiency 36 with lymphoproliferation, Immunodeficiency 36 with lymphoproliferation |
| RS1746796602 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS1746822963 |
AP3B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS1746847394 |
TRIO
|
Health Risk |
Likely pathogenic |
— |
| RS1746873504 |
MCCC2
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS1746954710 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS1746965734 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1747122771 |
NAA15
|
Health Risk |
Pathogenic |
— |
| RS1747146910 |
MAP1B
|
Health Risk |
Likely pathogenic |
— |
| RS1747192100 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS1747217573 |
NAA15
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1747234497 |
MAP1B
|
Health Risk |
Likely pathogenic |
MAP1B-related disorder, MAP1B-related disorder |
| RS1747269311 |
MCCC2
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS1747274021 |
MAP1B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1747328996 |
FST
|
Health Risk |
Conflicting classifications of pathogenicity |
Orofacial cleft, Orofacial cleft |
| RS1747335600 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS1747351128 |
TRIO
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1747351918 |
TRIO
|
Health Risk |
Pathogenic |
Inborn genetic diseases, TRIO-related disorder |
| RS1747352673 |
TRIO
|
Health Risk |
Likely pathogenic |
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome, Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome |
| RS1747357327 |
MCCC2
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS1747397763 |
MCCC2
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS1747474847 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS1747528071 |
PIK3R1
|
Health Risk |
Likely pathogenic |
Vascular Malformations and Overgrowth, Vascular Malformations and Overgrowth |
| RS1747530144 |
PIK3R1
|
Health Risk |
Likely pathogenic |
Vascular Malformations and Overgrowth, Overgrowth syndrome |
| RS1747532310 |
C6
|
Health Risk |
Pathogenic |
— |
| RS1747534368 |
SKIC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Trichohepatoenteric syndrome 1, Trichohepatoenteric syndrome 1 |
| RS1747566758 |
NIPBL
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1747567072 |
SKIC3
|
Health Risk |
Likely pathogenic |
— |
| RS1747568641 |
TERT
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal dominant 2 |
| RS1747569912 |
TERT
|
Health Risk |
Likely risk allele |
Pulmonary fibrosis, Pulmonary fibrosis |
| RS1747594790 |
KCNN2
|
Health Risk |
Pathogenic |
Global developmental delay, Cerebellar ataxia |
| RS1747595026 |
MCCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS1747639986 |
PIK3R1
|
Health Risk |
Likely pathogenic |
SHORT syndrome, SHORT syndrome |
| RS1747645807 |
PIK3R1
|
Health Risk |
Likely pathogenic |
Vascular Malformations and Overgrowth, CLOVES syndrome |
| RS1747653910 |
NIPBL
|
Health Risk |
Pathogenic |
— |
| RS1747658551 |
PIK3R1
|
Health Risk |
Pathogenic |
Vascular Malformations and Overgrowth, Colon adenocarcinoma |
| RS1747658707 |
PIK3R1
|
Health Risk |
Pathogenic |
Vascular Malformations and Overgrowth, Vascular Malformations and Overgrowth |
| RS1747667518 |
TRIO
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual developmental disorder, autosomal dominant 63 |
| RS1747667870 |
KIF2A
|
Health Risk |
Likely pathogenic |
Complex cortical dysplasia with other brain malformations 3, Complex cortical dysplasia with other brain malformations 3 |
| RS1747669042 |
TRIO
|
Health Risk |
Pathogenic/Likely pathogenic |
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome, Intellectual developmental disorder |
| RS1747685854 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS1747686698 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1747708267 |
PIK3R1
|
Health Risk |
Likely pathogenic |
Immunodeficiency 36 with lymphoproliferation, SHORT syndrome |
| RS1747827267 |
MTRR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblE, Methylcobalamin deficiency type cblE |
| RS1747853230 |
MTRR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblE, Methylcobalamin deficiency type cblE |
| RS1747866049 |
NAA15
|
Health Risk |
Pathogenic |
intellectual developmental disorder-50 with behavioral abnormalities (MRD50), intellectual developmental disorder-50 with behavioral abnormalities (MRD50) |
| RS1747930001 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic Pulmonary Fibrosis, Dyskeratosis congenita |
| RS1747980506 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1747989303 |
ARSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1747994028 |
NAA15
|
Health Risk |
Likely pathogenic |
— |
| RS1747996495 |
NAA15
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS1748005026 |
ARSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1748033 |
PADI4
|
Health Risk |
Benign; association |
Rheumatoid arthritis, Abnormal pulmonary interstitial morphology |
| RS17480581 |
CPAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Seckel syndrome 4, Microcephaly 6 |
| RS1748067893 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS1748093286 |
USP53
|
Health Risk |
Pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS1748100957 |
NAA15
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS1748101805 |
USP53
|
Health Risk |
Likely pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS1748106152 |
USP53
|
Health Risk |
Likely pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS1748122848 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS1748144362 |
NAA15
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1748153358 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS1748158034 |
TERT
|
Health Risk |
Likely risk allele |
Pulmonary fibrosis, Pulmonary fibrosis |
| RS1748194816 |
MAP3K1
|
Health Risk |
Likely pathogenic |
— |
| RS1748331186 |
MTRR
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS1748371268 |
MTRR
|
Health Risk |
Likely pathogenic |
Methylcobalamin deficiency type cblE, Methylcobalamin deficiency type cblE |
| RS1748372023 |
MTRR
|
Health Risk |
Likely pathogenic |
Methylcobalamin deficiency type cblE, Methylcobalamin deficiency type cblE |
| RS1748378605 |
AP3B1
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS1748397238 |
NAA15
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS1748431071 |
ERCC8
|
Health Risk |
Likely pathogenic |
— |